Epidemiological and clinical features of giant cell arteritis in Tunisia

European Journal of Internal Medicine

Volumn 20, Issue 2, 2009, Pages 208-212

  Khalifa, Mabrouk ^a   Karmani, Monia ^a   Jaafoura, Nairouz Ghannouchi ^a   Kaabia, Naoufel ^a   Letaief, Amel Omezzine ^a   Bahri, Fethi ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Epidemiology; Giant cell arteritis; Multicentric study; Temporal artery biopsy; Tunisia

Indexed keywords

CORTICOSTEROID DERIVATIVE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; AGED; ARTICLE; BLOOD VESSEL BIOPSY; CATARACT; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; CUSHINGOID SYNDROME; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; GIANT CELL ARTERITIS; GLAUCOMA; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PREVALENCE; RECURRENT DISEASE; REMISSION; TEMPORAL ARTERY; TREATMENT RESPONSE; TUNISIA;

AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; GIANT CELL ARTERITIS; HUMANS; MALE; MIDDLE AGED; NECROSIS; PREVALENCE; SEX DISTRIBUTION; TEMPORAL ARTERIES; TUNISIA;

EID: 62749129366     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.07.030     Document Type: Article

References (44)

1. Gonzalez-Gay M.A., and Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 27 (2001) 729-749
2. Levine S.M., and Hellmann D.B. Giant cell arteritis. Curr Opin Rheumatol 14 (2002) 3-10
3. Salvarani C., Cantini F., Boiardi L., and Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347 (2002) 261-271
4. Calvo-Romero J.M. Giant cell arteritis. Postgrad Med J 79 (2003) 511-515
5. Weyand C.M., and Goronzy J.J. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139 (2003) 505-515
6. Gurwood A.S., and Malloy K.A. Giant cell arteritis. Clin Exp Optom 85 (2002) 19-26
7. Huston K.A., and Hunder G.G. Giant cell (cranial) arteritis: a clinical review. Am Heart J 100 (1980) 99-105
8. Khan M.F., Peltier A.P., Meyer O., and Piete J.C. Maladie de Horton. Maladies et syndromes systémiques, Médécine-Sciences Fammarion (2000) 659-684
9. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33 (1990) 1122-1128
10. Salvarani C., Gabriel S.E., O'Fallon W.M., and Hunder G.G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123 (1995) 192-194
11. Franzen P., Sutinen S., and von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 19 (1992) 273-276
12. Noltorp S., and Svensson B. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community. Clin Exp Rheumatol 9 (1991) 351-355
13. Salvarani C., Macchioni P., Zizzi F., Mantovani W., Rossi F., Castri C., et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34 (1991) 351-356
14. Gonzalez-Gay M.A., Garcia-Porrua C., Rivas M.J., Rodriguez-Ledo P., and Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 60 (2001) 367-371
15. Gonzalez-Gay M.A., Lopez-Diaz M.J., Barros S., Garcia-Porrua C., Sanchez-Andrade A., Paz-Carreira J., et al. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine 84 (2005) 277-290
16. Huston K.A., Hunder G.G., Lie J.T., Kennedy R.H., and Elveback L.R. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 88 (1978) 162-167
17. Gonzalez-Gay M.A., Miranda-Filloy J.A., Lopez-Diaz M.J., Perez-Alvarez R., Gonzalez_Juanatey C., Sanchez-Andrade A., et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore) 86 (2007) 61-68
18. Gonzalez-Gay M.A., Barros S., Lopez-Diaz M.J., Garcia-Porrua C., Sanchez-Andrade A., and Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 84 (2005) 269-276
19. Liozon E., Herrmann F., Ly K., Robert P.Y., Loustaud V., Soria P., et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 111 (2001) 211-217
20. Hamidou M.A., Batard E., Trewick D., Masseau A., Moreau A., Agard C., et al. Silent versus cranial giant cell arteritis. Initial presentation and outcome of 50 biopsy-proven cases. Eur J Intern Med 16 (2005) 183-186
21. Liozon E., Boutros-Toni F., Ly K., Loustaud-Ratti V., Soria P., and Vidal E. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course. J Rheumatol 30 (2003) 1272-1276
22. Gonzalez-Gay M.A., Garcia-Porrua C., Amor-Dorado J.C., and Llorca J. Giant cell arteritis without clinically evident vascular involvement in a defined population. Arthritis Rheum 51 (2004) 274-277
23. Gonzalez-Gay M.A., Garcia-Porrua C., Llorca J., Hajeer A.H., Branas F., Dababneh A., et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in161 patients. Medicine 79 (2000) 283-292
24. Hayreh S.S., Podhajsky P.A., and Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125 (1998) 509-520
25. Tovilla-Canales J.L. Ocular manifestations of giant cell arteritis. Curr Opin Ophthalmol 9 (1998) 73-79
26. Gonzalez-Gay M.A., Blanco R., Rodriguez-Valverde V., Martinez-Taboada V.M., Delgado-Rodriguez M., Figueroa M., et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41 (1998) 1497-1504
27. Salvarani C., and Hunder G.G. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 45 (2001) 140-145
28. Martinez-Taboada V.M., Blanco R., Armona J., Uriarte E., Figueroa M., Gonzalez-Gay M.A., et al. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 19 (2000) 73-75
29. Jundt J.W., and Mock D. Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 34 (1991) 217-219
30. Chakrabarty A., and Franks A.J. Temporal artery biopsy: is there any value in examining biopsies at multiple levels?. J Clin Pathol 53 (2000) 131-136
31. Sudlow C. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy. BMJ 315 (1997) 549
32. Gonzalez-Gay M.A., Garcia-Porrua C., Llorca J., Gonzalea-Louzao C., and Rodriguez- Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30 (2001) 249-256
33. Schmidt W.A., Kraft H.E., Vorpahl K., Völker L., and Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337 6 (1997) 1336-1342
34. Stanson A.W. Imaging findings in extracranial temporal arteritis. Clin Exp Rheumatol 18 (2000) S43-S48
35. Ataly M.K., and Bluemke D.A. Magnetic resonance imaging of large vessel vasculitis. Curr Opin Rheumatol 13 (2001) 41-47
36. Chan C.C., Paine M., and O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol 85 (2001) 1061-1064
37. Ferraccioli G.F., Di Poi E., and Damato R. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives. Clin Exp Rheumatol 18 (2000) S58-S60
38. Delecoeuillerie G., Joly P., Cohen de Lara A., and Paolaggi J.B. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of Prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 47 (1988) 733-739
39. Gonzalez-Gay M. The diagnosis and management of patients with giant cell arteritis. Rheumatology 32 (2005) 1186-1188
40. Jover J.A., Hernandez-Garcia C., Morado I.C., Vargas E., Banares A., and Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 134 (2001) 106-114
41. Nesher G., Rubinow A., and Sonnenblick M. Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study. Clin Exp Rheumatol 15 (1997) 303-306
42. Nesher G., Sonnenblick M., and Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol 21 (1994) 1283-1286
43. Nuenninghoff D.M., Hunder G.G., Christianson T.J., McClelland R.L., and Matteson E.L. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48 (2003) 3522-3531
44. Gonzalez-Gay M.A., Garcia-Porrua C., Pieiro A., Pego-Reigosa R., Llorca J., and Hunder G.G. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 83 (2004) 335-341